Calendar

Hosted by Avi Spira, Professor of Medicine, Pathology & Laboratory Medicine, and Bioinformatics; Chief, Division of Computational Biomedicine; and Director, Boston University Cancer Center Discoveries about the molecular basis of disease and infection provide unprecedented opportunities to translate research into new medicines. However, developing a new drug is a costly, complex, and time-consuming process. Drug repurposing, the application of one compound or agent already used to treat a disease or condition to treat other illnesses, is gaining popularity as a potential solution to the barriers of medicine innovation. Likewise, compounds discovered previously and not pursed due to formulation issues are shelved and not explored. Recent advances in nanotechnology, genomics, and polymers are providing new opportunities to reposition these agents for clinical use. However, complex issues such as intellectual property rights for repurposed and re-discovered drugs, fear of discovery of adverse side effects, and others continue to deter many drug manufacturers and researchers. In this session, faculty from across the University will talk about their work in this area. RSVP